{"disease":{"id":"osteogenesis-imperfecta-type-iii","name":"osteogenesis imperfecta type iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03118570","title":"A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}